[{"id":"81bc2bae-b93f-4add-aac2-cc81988be7aa","acronym":"","url":"https://clinicaltrials.gov/study/NCT06056323","created_at":"2023-09-28T15:10:37.748Z","updated_at":"2024-07-02T16:35:32.257Z","phase":"Phase 1/2","brief_title":"A Study of HB0045 Injection in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT06056323","lead_sponsor":"Shanghai Huaota Biopharmaceutical Co., Ltd.","biomarkers":" MSI • CD4","pipe":"","alterations":" ","tags":["MSI • CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HB0045"],"overall_status":"Recruiting","enrollment":" Enrollment 71","initiation":"Initiation: 07/18/2023","start_date":" 07/18/2023","primary_txt":" Primary completion: 09/19/2025","primary_completion_date":" 09/19/2025","study_txt":" Completion: 03/19/2026","study_completion_date":" 03/19/2026","last_update_posted":"2023-10-20"},{"id":"b306e56a-2d10-4caa-85ba-c58e65dbeea0","acronym":"","url":"https://clinicaltrials.gov/study/NCT05944276","created_at":"2023-07-13T18:10:51.727Z","updated_at":"2024-07-02T16:35:43.117Z","phase":"Phase 1/2","brief_title":"A Study of HB0045 Injection in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05944276","lead_sponsor":"Huabo Biopharm Co., Ltd.","biomarkers":" MSI • CD4","pipe":"","alterations":" ","tags":["MSI • CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HB0045"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 71","initiation":"Initiation: 08/20/2023","start_date":" 08/20/2023","primary_txt":" Primary completion: 08/19/2025","primary_completion_date":" 08/19/2025","study_txt":" Completion: 03/19/2026","study_completion_date":" 03/19/2026","last_update_posted":"2023-07-13"}]